Article: A case of meropenem-induced liver injury and jaundice.
Journal of community hospital internal medicine perspectives
2021 Volume 11, Issue 1, Page(s) 143–144
Abstract: This report describes what we believe is the first reported case of clinically significant cholestasis and acute liver injury within three days of meropenem therapy. An 83-year-old Hispanic female was admitted for sepsis of unknown origin and was started ...
Abstract | This report describes what we believe is the first reported case of clinically significant cholestasis and acute liver injury within three days of meropenem therapy. An 83-year-old Hispanic female was admitted for sepsis of unknown origin and was started on intravenous meropenem. Three days following initiation of the antibiotic, the patient developed mixed hepatocellular and cholestatic liver injury with jaundice and pruritus. Possible causes of cholestasis were excluded after extensive investigations. A drug-induced liver injury was suspected and meropenem was discontinued. Following discontinuation of meropenem, the patient demonstrated symptomatic and laboratory improvements, and her liver enzymes and bilirubin levels were normalized. |
---|---|
Language | English |
Publishing date | 2021-01-26 |
Publishing country | United States |
Document type | Case Reports |
ZDB-ID | 2616884-4 |
ISSN | 2000-9666 |
ISSN | 2000-9666 |
DOI | 10.1080/20009666.2020.1845929 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.